Volume 3, Issue 7
To determine the Effect of Berberine on 6-OHDA induced memory impairment in Parkinson’s disease in rodents
Author: Vivek Kahale, Amrapali Mhaiskar, Priyanka Shelat, Pooja RU, Gaikwad NJ, Mundhada DR.
Abstract:
The relevant doses of Berberine administration in present preclinical study states that neurotoxicity induced by 6-Hydroxydopamine is remarkably neuroprotective in male wistar rats. 6-Hydroxydopamine induce Parkinson's disease (PD) which is a chronic and progressive neurodegenerative disease with loss of brown pigment neuromelanin with preferential loss of dopaminergic neurons of the substantia nigra pars compacta results in oxidative stress and mitochondrial disfunction. Berberine (BER) (2, 3-methylenedioxy-9, 10-dimethoxy protoberberine chloride) is an isoquinoline alkaloid from dried herb acts as a antioxidant and prevent reactive oxygen species (ROS) injury in various ways. Berberine treatments protects behavioral changes, significantly reduce oxidative damage & improved mitochondrial complex enzymes activities in different regions (striatum, cortex and hippocampus) of rat brain due to neurotoxicity. Administration of 6-Hydroxydopamine through I.C.V. produces hypo activity that resembles juvenile onset and advanced Parkinson's disease in rats. Berberine activity investigates the neuroprotective effect in animal model of Parkinson's disease.
Download Full Article: Click Here
Support Us
If you are interested in supporting our work and would like to contribute, you are welcome to mail me at jpbr.anil@gmail.com or at info@thepharmajournal.com it will be a great help and will surely be appreciated.
